These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4141548)

  • 1. [Long-term effects of the estrogen-gestagen combination preparation Ovosiston on glucose level in the insulin tolerance test].
    Goretzlehner G; Rudolf K; Töwe J
    Zentralbl Gynakol; 1974 Oct; 96(40):1249-53. PubMed ID: 4141548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of estrogen-gestagen drug combinations on carbohydrate and lipid metabolism. I. Effect of Ovosiston].
    Göretzlehner G; Herre HD; Töwe J
    Zentralbl Gynakol; 1973 Apr; 95(16):529-36. PubMed ID: 4123733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification of glucose tolerance and plasma insulin concentration by ovulation inhibitors].
    Waldhäusl W; Beringer A; Schneider W
    Geburtshilfe Frauenheilkd; 1969 Jul; 29(7):611-7. PubMed ID: 4184205
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of chlormadinone acetate and mestranol on blood glucose and plasma insulin. I. Six-month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Fertil Steril; 1971 Apr; 22(4):217-23. PubMed ID: 4101969
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of chlormadinone acetate and mestranol on blood glucose and plasma insulin. II. Twelfth month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Fertil Steril; 1971 Apr; 22(4):224-8. PubMed ID: 4101970
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral contraceptives: effects on carbohydrate metabolism, insulin like activity and histology of the pancreas.
    Kulkarni HJ; Gaitonde BB; Bandisode MS
    Horm Metab Res; 1980 Oct; 12(10):497-504. PubMed ID: 7002754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of estrogen-gestagen combinations on carbohydrate and lipid metabolism. IV. Effect of estrone-cyanate combination preparations].
    Göretzlehner G
    Zentralbl Gynakol; 1973 Dec; 95(52):1838-43. PubMed ID: 4131834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a contraceptive treatment with Ovosiston on the serum-cholinesterase activity].
    Willgerodt H; Rothe K; Theile H; Fischer I
    Zentralbl Gynakol; 1971 Sep; 93(36):1261-7. PubMed ID: 4106443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of an oral contraceptive on glucose-, F.F.A.-, triglyceride- and insulin levels after glucose loading.
    Terpstra P; Reitsma WD; Visser JW; Doorenbos H
    Folia Med Neerl; 1970; 13(2):44-50. PubMed ID: 5422992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB; Feustel S
    Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of ethynodiol diacetate and mestranol on blood glucose and plasma insulin. I. Six month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Int J Fertil; 1971; 16(2):55-65. PubMed ID: 5092534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of cyclic Ovosiston therapy on plasma lipid fractions of free cholesterol, total cholesterol and phospholipid].
    Carol W; Hempel E; Klinger G; Bünnig S
    Endokrinologie; 1970; 57(1):108-14. PubMed ID: 4099595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
    Steindel E; Mohnike A; Langreck G
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):159-61. PubMed ID: 4102493
    [No Abstract]   [Full Text] [Related]  

  • 14. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 15. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of minute gestagen doses on carbohydrate metabolism].
    Dittmar FW; Waidl E
    Geburtshilfe Frauenheilkd; 1969 Nov; 29(11):1026-31. PubMed ID: 4107126
    [No Abstract]   [Full Text] [Related]  

  • 17. [The action of Sequostat in comparison to Sequence Ovosiston on selected metabolic parameters].
    Etzrodt R; Klinger G; Carol W
    Zentralbl Gynakol; 1990; 112(8):489-96. PubMed ID: 1694614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and glucose studies after one year of treatment with a sequential-type oral contraceptive.
    Spellacy WN; Buhi WC; Bendel RP
    Obstet Gynecol; 1969 Jun; 33(6):800-4. PubMed ID: 4181554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ovosiston on the thrombelastogram].
    Sulek K; Grzeniewski L
    Ginekol Pol; 1972; 43(3):339-44. PubMed ID: 4112059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral contraceptives on carbohydrate metabolism.
    Vermeulen A; Daneels R; Thiery M
    Diabetologia; 1970 Oct; 6(5):519-23. PubMed ID: 4097526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.